Harbour Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
VCM
VPM
Harbour Investments's ABBV Position: Q1 2026 in Review
Harbour Investments increased its AbbVie (ABBV) stake by 33% in Q1 2026, buying an estimated $12.4M and bringing the position to 228,025 shares worth $49.6M. The position accounts for 0.77% of the portfolio, ranked #23.
Harbour Investments first reported a position in ABBV in Q1 2021 and has held it in 20 quarters since. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Harbour Investments held 228,025 shares of AbbVie worth $49.6M as of Q1 2026.
- Harbour Investments bought 55,990 AbbVie shares in Q1 2026, an estimated $12.4M.
- AbbVie made up 0.77% of Harbour Investments's portfolio in Q1 2026, its #23 holding.
- Harbour Investments first reported a position in AbbVie in Q1 2021 and has held it in 20 quarters since.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.